Researchers have identified the protein GLT-1 as the neurotransmitter glutamate transporter in the brain that is related to cortical spreading depression, a pathological condition that underlies migraines. The researchers found that mice lacking GLT-1, but not other glutamate receptors, were more susceptible to cortical spreading depression than were controls. GLT-1 might therefore be a potential target for migraine therapy.